Molecular switch for WNT5A/B expression through TCF-4 isoforms in human liver cancer cells
Project/Area Number |
26461025
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Kurume University |
Principal Investigator |
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | Wntシグナル / T-cell factor-4 / 癌幹細胞 / TCF-4 / Wnt / isoform / Hes1 / Notch |
Outline of Final Research Achievements |
We have demonstrated that a mutant isoform (269A) of the SxxSS-harboring TCF-4K robustly expressed WNT5A at both mRNA and protein levels in human liver cancer cells. ChIP assay revealed that the mutant TCF-4 could directly bind to promoter region of WNT5A gene, suggesting the motif contributed to regulate the gene expression. Knockdown of WNT5A resulted in upregulation of the EMT regulator SLUG. These findings suggest that TCF-4 regulates WNT5A expression in a SxxSS motif-dependent manner, thereby contributing to phenotypic changes, including EMT. I addition, HIPK-2 was suggested to be responsible for phosphorylation of serine residues of SxxSS.
|
Report
(4 results)
Research Products
(26 results)
-
[Journal Article] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1.2017
Author(s)
Ikezono Y, Koga H, Akiba J, Abe M, Yoshida T, Wada F, Nakamura T, Iwamoto H, Masuda A, Sakaue T, Yano H, Tsuruta O, Torimura T.
-
Journal Title
Molecular Cancer Research
Volume: -
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study.2016
Author(s)
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Satani M, Niizeki T, Okamura S, Iwamoto H, Shimose S, Shirono T, Noda Y, Koga H, Torimura T; Kurume Liver Cancer Study Group Of Japan.
-
Journal Title
Oncotarget
Volume: 7
Issue: 39
Pages: 64400-64409
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Ex vivo expansion of circulating CD34+ cells enhances the regenerative effect on rat liver cirrhosis2016
Author(s)
Toru Nakamura, Hironori Koga, Hideki Iwamoto, Victor Tsutsumi, Yasuko Imamura, Masako Naitou, Atsutaka Masuda, Yu Ikezono, Mitsuhiko Abe, Fumitaka Wada, Takahiko Sakaue, Takato Ueno, Masaaki Ii, Cantas Alev, Atsuhiko Kawamoto, Takayuki Asahara, Takuji Torimura
-
Journal Title
Molecular Therapy - Methods & Clinical Development
Volume: 3
Pages: 1-13
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.2016
Author(s)
Torimura T, Iwamoto H, Nakamura T, Abe M, Ikezono Y, Wada F, Sakaue T, Masuda H, Hashimoto O, Koga H, Ueno T, Yano H.
-
Journal Title
Neoplasia
Volume: 18
Issue: 7
Pages: 413-424
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.2016
Author(s)
Nagamatsu H, Sumie S, Niizeki T, Tajiri N, Iwamoto H, Aino H, Nakano M, Shimose S, Satani M, Okamura S, Kuromatsu R, Matsugaki S, Kurogi J, Kajiwara M, Koga H, Torimura T.
-
Journal Title
Cancer Chemotherapy and Pharmacology
Volume: 77
Issue: 2
Pages: 243-250
DOI
Related Report
Peer Reviewed
-
[Journal Article] High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors.2015
Author(s)
Ikezono YU, Koga H, Abe M, Akiba J, Kawahara A, Yoshida T, Nakamura T, Iwamoto H, Yano H, Kage M, Sata M, Tsuruta O, Torimura T.
-
Journal Title
Oncology Letters
Volume: 10
Issue: 4
Pages: 2015-2020
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study.2015
Author(s)
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Tajiri N, Satani M, Niizeki T, Aino H, Okamura S, Iwamoto H, Shimose S, Shirono T, Koga H, Torimura T; Kurume Liver Cancer Study Group of Japan.
-
Journal Title
Cancer Medicine
Volume: 12
Issue: 12
Pages: 1836-1843
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Inhibition of hypoxia-inducible factor via upregulation of von Hippel-Lindau protein induces "angiogenic switch off" in a hepatoma mouse model.2015
Author(s)
Iwamoto H, Nakamura T, Koga H, Izaguirre-Carbonell J, Kamisuki S, Sugawara F, Abe M, Iwabata K, Ikezono Y, Sakaue T, Masuda A, Yano H, Ohta K, Nakano M, Shimose S, Shirono T, Torimura T.
-
Journal Title
Molecular Therapy Oncolytics
Volume: 2
Pages: 15020-15020
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] CD34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis2014
Author(s)
Nakamura T, Torimura T, Iwamoto H, Kurogi J, Inoue H, Hori Y, Sumie S, Fukushima N, Sakata M, Koga H, et al.
-
Journal Title
J Gastroenterol Hepatol
Volume: (in press)
Issue: 10
Pages: 1830-1838
DOI
Related Report
Peer Reviewed
-
-
[Presentation] TCF-4 isoform upregulates CLAUDIN-2, thereby activating NOTCH signaling in human liver cancer cells2016
Author(s)
Koga H, Wada F, Akiba J, Ikezono Y, Iwamoto H, Nakamura T, Masuda A, Sakaue T, Yano H, Torimura T.
Organizer
第75回 日本癌学会学術総会
Place of Presentation
横浜
Year and Date
2016-10-06
Related Report
-
-
-
-
-
-
-
-
-
-
[Presentation] The Wnt signal transcription factor TCF-4 directly regulates Bcl-xL expression in human hepatocellular carcinoma cells2014
Author(s)
Hironori Koga, Miran Kim, Anna Nakamura, Hirohisa Yano, Mitsuhiko Abe, Yu Ikezono, Toru Nakamura, Takuji Torimura, Jack R. Wands, and Michio Sata
Organizer
AACR 2014
Place of Presentation
San Diego Convention Center, San Diego, CA, USA
Year and Date
2014-04-06
Related Report
-
-